neo-gambogic acid has been researched along with cyclin d1 in 2 studies
Studies (neo-gambogic acid) | Trials (neo-gambogic acid) | Recent Studies (post-2010) (neo-gambogic acid) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
---|---|---|---|---|---|
63 | 0 | 59 | 10,885 | 70 | 5,157 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, H; Fang, N; Li, Q; Peng, D; Su, J; Wang, M; Wang, X; Xia, L; Xu, Q; Yang, L; Zhou, A; Zhu, G | 1 |
Gao, J; Han, QB; Ma, L; Wen, ZS; Yu, XJ; Zhou, GB | 1 |
2 other study(ies) available for neo-gambogic acid and cyclin d1
Article | Year |
---|---|
Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulation; Female; Garcinia; Gene Expression Regulation; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Plant Extracts; Resins, Plant; RNA, Messenger; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2010 |
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Terpenes; TOR Serine-Threonine Kinases; Xanthenes; Xanthones | 2012 |